Baidu
map

转化医学指南

订阅

MedSci主页 / 所有栏目 / 转化医学指南

从宏基因组测序推断的微生物组成数据的统计分析指南

2021-10-01 Curr Issues Mol Biol . 2017;24:17-36

宏基因组宏基因组学宏基因组学测序

从宏基因组测序推断的微生物组成数据的统计分析指南

中文标题：

从宏基因组测序推断的微生物组成数据的统计分析指南

英文标题：

Guidelines to Statistical Analysis of Microbial Composition Data Inferred from Metagenomic Sequencing

发布机构：

发布日期：

2021-10-01

简要介绍：

从宏基因组测序推断的微生物组成数据的统计分析指南

宏基因组学是将高通量 DNA 测序应用于环境样本调查，彻底改变了我们对复杂微生物群落的分类学和遗传组成的看法。在从生物医学、食品工业到地质学等各个领域的背景下，丰富的微生物群不断展现。宏基因组读数的初步分析允许推断描述群落结构的半定量数据。但是，此类组成数据具有统计特定属性，在预处理、假设检验和解释统计检验结果期间需要考虑这些属性。未能考虑到这些细节可能会导致调查结果出现本质上错误的结论。在这里，我们向宏基因组学领域介绍了一位研究人员，介绍了微生物组成数据的基本属性，包括统计功效和提议的分布模型，对专门为此类数据开发的公开可用软件工具进行了审查，并概述了应用方法。

相关资料下载：
[AttachmentFileName(sort=1, fileName=1.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e53fc1c002221af8, title=从宏基因组测序推断的微生物组成数据的统计分析指南, enTitle=Guidelines to Statistical Analysis of Microbial Composition Data Inferred from Metagenomic Sequencing, guiderFrom=Curr Issues Mol Biol . 2017;24:17-36, authorId=0, author=, summary=从宏基因组测序推断的微生物组成数据的统计分析指南, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Oct 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>从宏基因组测序推断的微生物组成数据的统计分析指南</p> <p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0" data-number-of-phrases="1">宏基因组学是将高通量 DNA 测序应用于环境样本调查，彻底改变了我们对复杂微生物群落的分类学和遗传组成的看法。在从生物医学、食品工业到地质学等各个领域的背景下，丰富的微生物群不断展现。宏基因组读数的初步分析允许推断描述群落结构的半定量数据。但是，此类组成数据具有统计特定属性，在预处理、假设检验和解释统计检验结果期间需要考虑这些属性。未能考虑到这些细节可能会导致调查结果出现本质上错误的结论。在这里，我们向宏基因组学领域介绍了一位研究人员，介绍了微生物组成数据的基本属性，包括统计功效和提议的分布模型，对专门为此类数据开发的公开可用软件工具进行了审查，并概述了应用方法。</span></span></p>, tagList=[TagDto(tagId=36470, tagName=宏基因组), TagDto(tagId=43260, tagName=宏基因组学), TagDto(tagId=105742, tagName=宏基因组学测序)], categoryList=[CategoryDto(categoryId=42, categoryName=转化医学, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=48002, appHits=43, showAppHits=0, pcHits=465, showPcHits=47958, likes=1, shares=3, comments=6, approvalStatus=1, publishedTime=Thu Oct 21 18:34:20 CST 2021, publishedTimeString=2021-10-01, pcVisible=1, appVisible=1, editorId=4754896, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=小小医者, createdTime=Thu Oct 21 12:54:19 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Fri Jan 05 20:18:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=1.pdf)])
1.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1062872, encodeId=689a10628e23c, content=学到了很多东西，谢谢老师的指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Fri Oct 22 09:55:59 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062760, encodeId=c57a1062e6003, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210926/25301c60248648b0a93bab21015a86f5/963f4290a8f24e0c884eddcf0a1cffc2.jpg, createdBy=c0e35149677, createdName=谭永娇, createdTime=Thu Oct 21 22:40:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062743, encodeId=c3fa1062e4388, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Thu Oct 21 21:53:11 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062716, encodeId=c9c11062e1680, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062715, encodeId=52891062e1580, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:03 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2021-10-22 1436749007

    学到了很多东西，谢谢老师的指导

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1062872, encodeId=689a10628e23c, content=学到了很多东西，谢谢老师的指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Fri Oct 22 09:55:59 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062760, encodeId=c57a1062e6003, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210926/25301c60248648b0a93bab21015a86f5/963f4290a8f24e0c884eddcf0a1cffc2.jpg, createdBy=c0e35149677, createdName=谭永娇, createdTime=Thu Oct 21 22:40:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062743, encodeId=c3fa1062e4388, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Thu Oct 21 21:53:11 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062716, encodeId=c9c11062e1680, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062715, encodeId=52891062e1580, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:03 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2021-10-21 谭永娇

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1062872, encodeId=689a10628e23c, content=学到了很多东西，谢谢老师的指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Fri Oct 22 09:55:59 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062760, encodeId=c57a1062e6003, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210926/25301c60248648b0a93bab21015a86f5/963f4290a8f24e0c884eddcf0a1cffc2.jpg, createdBy=c0e35149677, createdName=谭永娇, createdTime=Thu Oct 21 22:40:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062743, encodeId=c3fa1062e4388, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Thu Oct 21 21:53:11 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062716, encodeId=c9c11062e1680, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062715, encodeId=52891062e1580, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:03 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2021-10-21 ms4000000654879381

    赚积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1062872, encodeId=689a10628e23c, content=学到了很多东西，谢谢老师的指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Fri Oct 22 09:55:59 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062760, encodeId=c57a1062e6003, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210926/25301c60248648b0a93bab21015a86f5/963f4290a8f24e0c884eddcf0a1cffc2.jpg, createdBy=c0e35149677, createdName=谭永娇, createdTime=Thu Oct 21 22:40:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062743, encodeId=c3fa1062e4388, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Thu Oct 21 21:53:11 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062716, encodeId=c9c11062e1680, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062715, encodeId=52891062e1580, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:03 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2021-10-21 1207866fm50(暂无昵称)

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1062872, encodeId=689a10628e23c, content=学到了很多东西，谢谢老师的指导, beContent=null, objectType=guider, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5b3006368, createdName=1436749007, createdTime=Fri Oct 22 09:55:59 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062760, encodeId=c57a1062e6003, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210926/25301c60248648b0a93bab21015a86f5/963f4290a8f24e0c884eddcf0a1cffc2.jpg, createdBy=c0e35149677, createdName=谭永娇, createdTime=Thu Oct 21 22:40:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062743, encodeId=c3fa1062e4388, content=赚积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Thu Oct 21 21:53:11 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062716, encodeId=c9c11062e1680, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:41 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062715, encodeId=52891062e1580, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Thu Oct 21 21:04:03 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
    2021-10-21 1207866fm50(暂无昵称)

    谢谢分享

    0

相关指南

宏基因组分析和诊断技术在急危重症感染应用的专家共识

暂未更新 · 2019-02-12

Baidu
map
Baidu
map
Baidu
map